ADRX

Conviction 0Scan · Mon, Oct 5, 2026

ADARx Pharmaceuticals, Inc. (ADRX) closed at $18.83 (+3.18%) on Oct 5, 2026. -8.8% from its 52-week high, -2.7% year to date. Sector: Pharmaceutical Preparations.

ADRX$18.83+3.18%

ResistanceSupportVol 14Insider buy

Sep 25Sep 28Sep 29Oct 1Oct 2Oct 5

ADARx Pharmaceuticals, Inc.Pharmaceutical Preparations

Price18.83

Change+3.18%

Gap+1.21%

Rel volume0.99×

Avg volume1.57M

Avg $ vol30.5M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high20.64

52w low18.25

From 52w high-8.75%

Above 52w low+3.18%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)19.94

vs AVWAP high-5.57%

AVWAP (52w low)18.52

vs AVWAP low+1.70%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.99×

Avg vol (14d)—

Avg vol (20d)1.57M

Avg $ vol (20d)30.5M

Market cap—

RS Rating—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank11.8

1 week-6.27%

1 month—

3 months—

6 months—

1 year—

YTD-2.69%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank11.8 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in ADRX

All disclosures →

No recent disclosed trades by Congress in ADRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADRX · open-market 2 buys

Insider	Side	Shares	Value	Traded	Filed
George Simeon Director · Common Stock · 2026-09-28	Convert	3.33M	—	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Convert	1.11M	—	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Convert	512.9K	—	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Buy	592.59K	$10M	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Convert	1.54M	—	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Buy	414.81K	$7.1M	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Convert	1.67M	—	2026-09-28	2026-09-29
George Simeon Director · Common Stock · 2026-09-28	Convert	169K	—	2026-09-28	2026-09-29
George Simeon Director · Series B Preferred Stock · 2026-09-28	Convert	3.91M	—	2026-09-28	2026-09-29
George Simeon Director · Series B-1 Preferred Stock · 2026-09-28	Convert	1.3M	—	2026-09-28	2026-09-29

SEC filings

EDGAR filings in ADRX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

ADRX

Recent news

Get daily signals & real-time alerts.